True. This is true because when you do workouts you enjoy of listen to music you enjoy while working out you'll want to work out longer
Answer : An atom with 7 protons, 6 neutrons,
and 7 electrons has an atomic mass of 13 amu.
Explanation:
As we are give that,
Number of protons
7
Number of electrons =7
Number of neutrons =6
As we know that,
Atomic number =Number of protons = Number
of electrons =7
Atomic mass = Number of neutrons + Atomic
number
Atomic mass = 6 + 7 = 13 amu
Therefore, the atomic mass is, 13 amu
no. a person cannot be carrier of a dominant genetic disorder. if a certain disorder is a result of dominant gene both the homozygous and heterozygous individuals are sick and no one of them is carrier. The carrier state is seen only in a situation where genetic disorder is expressed when individuals inherits recessive alleles each from each parent. for someone to be a carrier in this situation, he/she must be heterozygous for certain disorder that is only expressed when an individuals is homozygous of recessive allelles.
“The test of any theory is whether or not it provides answers to basic questions. Some well-meaning but misguided people think evolution is a reasonable theory to explain man’s questions about the universe.”Where did the space for the universe come from? Witch can be experimented to answer.
Answer:
Instead of physically trapping drugs into vesicles, amphiphilic phospholipids in pharmacosomes are complexed with drugs via hydrogen bonds between active hydrogens and phospholipids. The drug molecule bearing an active hydrogen atom (-COOH, -OH, -NH2 etc.) can be converted to an ester with the hydroxyl moiety of the lipid, resulting in an amphiphilic complex that aids membrane, tissue, or cell wall transfer. The drug-lipid complex exists as a monomer at low concentrations, but a variety of structures (e.g. micelles, colloidal or hexagonal shape) might develop when the concentration increases. Eventually, the conjugated drug will be released from pharmacosomes upon chemical or enzymatic hydrolysis. Compared to other liposomal drug delivery systems, pharmacosomes have advantages such as minimized drug degradation and increased drug bioavailability. For example, limitations in transfersomes such as predisposition to oxidative degradation and impurity of natural phospholipids can be overcome by pharmacosomes. Besides, other advantages are also beneficial in various research:
No drug leakage due to the covalently link.
High entrapment efficiency.
Suitable for both hydrophilic and lipophilic drugs.
Improved bioavailability especially in case of poorly soluble drugs.
No need to remove unentrapped drugs from the formulation as needed in case of liposomes.
Reduction in adverse effects, toxicity, and the cost of therapy.
Avoid drug incorporation in the body of the patient.
Membrane fluidity does not affect drug release.
Explanation:
https://www.creative-biostructure.com/Pharmacosomes-Production-615.htm